Toshio Fujino

5PUBLICATIONS
37CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 30, 2023
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell Lung Cancer.

Sun Min Lim, Toshio Fujino, Chulwon Kim

|Jul 23, 2021
Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges.

Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi

|Jul 04, 2020
Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.

Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi

Pageof 1